Global Neurosurgery Drugs Market size is expected to reach nearly US$ 2727 Mn by 2029 with the CAGR of 8.4% during the forecast period. The global Neurosurgery Drugs market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Neurosurgery Drugs market report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Global Neurosurgery Drugs Market Overview
The market for Neurosurgical drugs is expected to register growth at a fast rate during the forecast period Neurosurgical drugs are medications that are administered to patients who are suffering and to manage diseases, disorders, and conditions that are affecting the brain and the nervous system. Symptoms of these diseases may affect a patient's brain or functions of the body that it controls which needs intensive care. Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.Global Neurosurgery Drugs Market Dynamics
Increases in the old age population and rising mental illness are the major factors that are driving the neurosurgery drugs market. As the old age population is more prone to neurological diseases like Alzheimer's, Neurotic Pain, Cardiac Glycoside Intoxication which require medical attention. With the increase in Neurological patients globally the neurosurgery drugs market is anticipated to grow in the coming years. The rising number of brain surgery primarily due to fatal road accidents mostly among young and adult people combined with advancements in the technology for performing neurosurgeries is also fueling the market. As the brain is the most important organ in the human body the demand for surgeons on the rise as well. Approximately 1.35 million people die due to damage caused to the brain in road accidents. And as per the reports around 6.8 million people die due to neurological disorders. An increase in the neurosurgeon is also driving the market due to their qualification, presence, and assistance through drugs & medications for treating patients. Most of the neurosurgeons have tie-ups with hospitals and specialty centers which helps in treating neurological patients. Due to which the market is expected to grow more drugs market. Other factors include the rise of investments in research and development for the production of new effective drugs. However, several factors such as government intervention and restriction in the medical field, high cost of neurosurgeries & their treatment combined with the difficulty in getting approval for new novel drugs for treatment will restrain the neurosurgery drugs market from growingSegment Analysis
Based on the drug class segment, the neurosurgery drugs market is dominated by Phenytoin drugs. It helps in controlling certain types of seizures and preventing them which may occur during surgery of the brain or nervous system as well. This drug comes under the class of anticonvulsants and its primary objectives include controlling electrical activity in the brain and treating epilepsy. Phenytoin is also used to control irregular heartbeats on the recommendation of a doctor and is available in tablet form due to which the segment is anticipated to grow more. The segment of Fosphenytoin of drug class is also anticipated to register growth in the market due to its use as an alternative to the phenytoin drug. It helps in reducing impulse in the brain that causes seizures. However, people who have a slow heartbeat or Adam stroke syndrome must avoid taking this drug. It is injected into the muscle through an IV. Based on the Disease segment, the Status Epileptics is dominating the market of neurosurgical drugs. This is due to pain caused by them which may lead to the death of the person. If the pain lasts longer than 5 minutes then it requires a medical emergency. Whereas the segment of Neuropathic Pain is also witnessing growth due to an increase in the disorder in the patient it is caused by the damage that occurred to the nerves that transfer the information between the brain and spinal cord from muscle, skin, and other parts of the body, and is also caused by damage to the nerves after surgery and trauma. Which will boost the sale of certain drugs for their treatment in the market Based on the Distribution Channel segment, hospital pharmacies are on the rise due to an increase in the number of patients preferring hospital treatment over certain clinical and independent Distribution Channel. Hospital pharmacies make available medication and drugs on time for the treatment and government support is also a major factor driving the Neurosurgery Drugs market. Retail Pharmacies have also seen an upsurge in the market due to an increase in awareness among people about neurological conditions and the availability of medications. Tie-ups neurosurgeons and neurologist with the certain pharmacist is the key factor which is driving the market growth
Regional Insights:
North America holds the largest market share in the market due to the high geriatric population in the region. The presence of major key players in the market and the availability of qualified neurosurgeons, rise in the investment for innovation and development in the neurological and medical field in the market are further propelling the market. Innovation is the process of treating patients and post-surgery assistance is also driving the market. USA, Canada, and Mexico are the major contributors in the region. Europe is the second-largest market due to an increase in the usage of pain relief medications and rising levels of stress among adults and young populations. Other factors include the rise in the awareness of neurosurgical disorders and post-surgery traumas in people. it has boosted the sale of drugs used for the treatment of these disorders. a rise in the launch of new drugs is expected to grow the market in the forecast period. France and Germany are leading the market in the region Asia Pacific region has also seen an upsurge in the market due to an increase in the stress level and technological advancements in the region. Over the last 20 years, Asia Pacific has continued to keep high economic growth rates and is termed a global economic center. Major key players of the region increasing their investment in the production of new drugs and their approval from the authorities for clinical usage in the market is driving the market, China and India are anticipated to hold the major market share in the region. The Middle East and Africa have also shown growth rates due to an increase in the awareness of healthcare and serious consequences of ill-treatment of neurological and post neurosurgery disorders. The shifting of international key payers in the region is expected to boost the market further in the region. The objective of the report is to present a comprehensive analysis of the Global Neurosurgery Drugs market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Neurosurgery Drugs Market dynamics, structure by analyzing the market segments and project the Global Neurosurgery Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurosurgery Drugs Market make the report investor’s guide.Global Neurosurgery Drugs Market Scope: Inquire before buying
Neurosurgery Drugs Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1550 Mn. Forecast Period 2023 to 2029 CAGR: 8.4% Market Size in 2029: US $ 2727 Mn. Segments Covered: by Drug Class Phenytoin Fosphenytoin Phenytoin Sodium Phenyte by Disease Neuropathic Pain Cardiac Gycoside Intoxication, Cardiac arrhythmias, Status epileptics, Seizures associated with neurosurgery, Absence (petit mal) seizures, Tonic-clonic seizures by Distribution Channel Retail pharmacies Hospital pharmacies Online pharmacies Global Neurosurgery Drugs Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest) South America (Brazil, Argetina and Rest of South America)Global Neurosurgery Drugs Market Key Players
1. Pfizer 2. AstraZeneca 3. Biogen 4. Jhonson & Jhonson 5. ABBVIE 6. Takeda Pharmaceuticals 7. UCB 8. IPSEN 9. Standigm 10. BlueStar Genomic 11. Tonix Pharmaceuticals 12. BlackThorn Therapeutics 13. Quentrix 14. Wren PharmaceuticalsFrequently Asked Questions:
1. Which region has the largest share in Global Neurosurgery Drugs Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Neurosurgery Drugs Market? Ans: The Global Neurosurgery Drugs Market is growing at a CAGR of 8.4% during forecasting period 2023-2029. 3. What is scope of the Global Neurosurgery Drugs Market report? Ans: Global Neurosurgery Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What was the Global Neurosurgery Drugs Market size in 2022? Ans: The Global Neurosurgery Drugs market was valued at US$ 1550 Mn. In 2022. 5. What is the study period of this Market? Ans: The Global Neurosurgery Drugs Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Distribution Channel 2.3.2. Primary Research 2.3.2.1. Data from Primary Distribution Channel 2.3.2.2. Breakdown of Primary Distribution Channel 3. Executive Summary: Global Neurosurgery Drugs Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Neurosurgery Drugs Drug Classs Market 3.4. Geographical Snapshot of the Neurosurgery Drugs Drug Classs Market, By Manufacturer share 4. Global Neurosurgery Drugs Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Drug Classs 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Neurosurgery Drugs Market 5. Supply Side and Demand Side Indicators 6. Global Neurosurgery Drugs Market Analysis and Forecast, 2022-2029 6.1 Neurosurgery Drugs Market Size & Y-o-Y Growth Analysis 7. Global Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 7.1.1. Phenytoin 7.1.2. Fosphenytoin 7.1.3. Phenytoin Sodium 7.1.4. Phenytek 7.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 7.2.1. Neuropathic Pain 7.2.2. Cardiac Gycoside Intoxication, 7.2.3. Cardiac arrhythmias, 7.2.4. Status epileptics, 7.2.5. Seizures associated with neurosurgery, 7.2.6. Absence (petit mal) seizures, 7.2.7. Tonic-clonic seizures 7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 7.3.1. Retail pharmacies 7.3.2. Hospital pharmacies 7.3.3. Online pharmacies 7.4. Market Size (Value) Estimates & Forecast by Region, 2022-2029 7.4.1. North America 7.4.2. South America 7.4.3. Europe 7.4.4. Asia Pacific 7.4.5. Middle East and Africa 8. North America Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 8.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 8.1.1. Phenytoin 8.1.2. Fosphenytoin 8.1.3. Phenytoin Sodium 8.1.4. Phenytek 8.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 8.2.1. Neuropathic Pain 8.2.2. Cardiac Gycoside Intoxication, 8.2.3. Cardiac arrhythmias, 8.2.4. Status epileptics, 8.2.5. Seizures associated with neurosurgery, 8.2.6. Absence (petit mal) seizures, 8.2.7. Tonic-clonic seizures 8.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 8.3.1. Retail pharmacies 8.3.2. Hospital pharmacies 8.3.3. Online pharmacies 9. North America Neurosurgery Drugs Market Analysis and Forecasts, By Country 9.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 9.1.1. US 9.1.2. Canada 9.1.3. Mexico 10. U.S. Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 10.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 10.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 10.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 11. Canada Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 12. Mexico Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 13. Europe Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 14. Europe Neurosurgery Drugs Market Analysis and Forecasts, By Country 14.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 14.1.1. U.K 14.1.2. France 14.1.3. Germany 14.1.4. Italy 14.1.5. Spain 14.1.6. Sweden 14.1.7. CIS Countries 14.1.8. Rest of Europe 15. U.K. Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 15.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 15.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 15.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 16. France Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 17. Germany Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 18. Italy Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 19. Spain Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 20. Sweden Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 21. CIS Countries Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 22. Rest of Europe Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 23. Asia Pacific Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 24. Asia Pacific Neurosurgery Drugs Market Analysis and Forecasts, by Country 24.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 24.1.1. China 24.1.2. India 24.1.3. Japan 24.1.4. South Korea 24.1.5. Australia 24.1.6. ASEAN 24.1.7. Rest of Asia Pacific 25. China Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 25.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 25.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 25.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 26. India Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 27. Japan Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 28. South Korea Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 29. Australia Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 29.4. Market Size (Value) Estimates & Forecast By Region, 2022-2029 30. ASEAN Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 31. Rest of Asia Pacific Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 32. Middle East Africa Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 33. Middle East Africa Neurosurgery Drugs Market Analysis and Forecasts, by Country 33.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 33.1.1. South Africa 33.1.2. GCC Countries 33.1.3. Egypt 33.1.4. Nigeria 33.1.5. Rest of ME&A 34. South Africa Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 34.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 34.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 34.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 35. GCC Countries Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 36. Egypt Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 37. Nigeria Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 38. Rest of ME&A Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 39. South America Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 40. South America Neurosurgery Drugs Market Analysis and Forecasts, by Country 40.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 40.1.1. Brazil 40.1.2. Argentina 40.1.3. Rest of South America 41. Brazil Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 41.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 41.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 41.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 42. Argentina Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 43. Rest of South America Neurosurgery Drugs Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Drug Class, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Disease, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 44. Competitive Landscape 44.1. Geographic Footprint of Major Players in the Global Neurosurgery Drugs Market 44.2. Competition Matrix 44.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Distribution Channels and R&D Investment 44.2.2. New Drug Class Launches and Drug Class Enhancements 44.2.3. Market Consolidation 44.2.3.1. M&A by Regions, Investment and Verticals 44.2.3.2. M&A, Forward Integration and Backward Integration 44.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 44.3. Company Profile : Key Players 44.3.1. Pfizer 44.3.1.1. Company Overview 44.3.1.2. Financial Overview 44.3.1.3. Geographic Footprint 44.3.1.4. Drug Class Portfolio 44.3.1.5. Business Strategy 44.3.1.6. Recent Developments 45.3.2 AstraZeneca 45.3.3 Biogen 45.3.4 Jhonson & Jhonson 45.3.5 ABBVIE 45.3.6 Takeda Pharmaceuticals 45.3.7 UCB 45.3.8 IPSEN 45.3.9 Standigm 45.3.10 BlueStar Genomic 45.3.11 Tonix Pharmaceuticals 45.3.12 BlackThorn Therapeutics 45.3.13 Quentrix 45.3.14 Wren Pharmaceuticals 45.3.15 Others 46 Primary Key Insight